RUNX1 and cancer: ,31,32 Consistent with the KOPTK1 observations, RUNX1-KO led to ∼50% reduction of H3K27ac levels in all three cell lines (Figures 1H and S3A–S3D) suggesting that RUNX1 associated loss of genome-wide H3K27ac density may be generalizable across cancer types.